Ola Börjesson

682 total citations
11 papers, 512 citations indexed

About

Ola Börjesson is a scholar working on Pulmonary and Respiratory Medicine, Immunology and Rheumatology. According to data from OpenAlex, Ola Börjesson has authored 11 papers receiving a total of 512 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 5 papers in Immunology and 4 papers in Rheumatology. Recurrent topics in Ola Börjesson's work include Vasculitis and related conditions (7 papers), Inflammasome and immune disorders (2 papers) and Otitis Media and Relapsing Polychondritis (2 papers). Ola Börjesson is often cited by papers focused on Vasculitis and related conditions (7 papers), Inflammasome and immune disorders (2 papers) and Otitis Media and Relapsing Polychondritis (2 papers). Ola Börjesson collaborates with scholars based in Sweden, Bangladesh and France. Ola Börjesson's co-authors include Iva Gunnarsson, Lars Klareskog, Per Eriksson, Maja Jagodic, Juha Kere, Olle Lidman, Holger Luthman, Eva Åkesson, Pia Lundman and Lars Alfredsson and has published in prestigious journals such as Nature Genetics, Annals of the Rheumatic Diseases and Arthritis Research & Therapy.

In The Last Decade

Ola Börjesson

10 papers receiving 501 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ola Börjesson Sweden 7 303 209 92 68 68 11 512
Zerai Manna United States 11 480 1.6× 263 1.3× 141 1.5× 53 0.8× 56 0.8× 17 646
Haruka Tsuchiya Japan 14 196 0.6× 188 0.9× 111 1.2× 52 0.8× 38 0.6× 31 512
G Sturfelt Sweden 9 246 0.8× 282 1.3× 59 0.6× 47 0.7× 29 0.4× 10 434
Mirko Scarsi Italy 12 218 0.7× 181 0.9× 54 0.6× 36 0.5× 34 0.5× 18 454
Y.W. Song South Korea 7 271 0.9× 274 1.3× 119 1.3× 33 0.5× 47 0.7× 25 525
Tal Gazitt Israel 12 224 0.7× 221 1.1× 98 1.1× 30 0.4× 22 0.3× 31 437
Masahiro Ayano Japan 14 238 0.8× 188 0.9× 96 1.0× 66 1.0× 35 0.5× 40 532
Yoshie Sanayama Japan 10 171 0.6× 332 1.6× 79 0.9× 45 0.7× 16 0.2× 17 582
Hongyu Yang United States 6 508 1.7× 256 1.2× 108 1.2× 138 2.0× 22 0.3× 11 803
Martin Judex Germany 11 137 0.5× 233 1.1× 147 1.6× 29 0.4× 37 0.5× 19 477

Countries citing papers authored by Ola Börjesson

Since Specialization
Citations

This map shows the geographic impact of Ola Börjesson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ola Börjesson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ola Börjesson more than expected).

Fields of papers citing papers by Ola Börjesson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ola Börjesson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ola Börjesson. The network helps show where Ola Börjesson may publish in the future.

Co-authorship network of co-authors of Ola Börjesson

This figure shows the co-authorship network connecting the top 25 collaborators of Ola Börjesson. A scholar is included among the top collaborators of Ola Börjesson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ola Börjesson. Ola Börjesson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Börjesson, Ola, et al.. (2025). Incidence and prevalence of granulomatosis with polyangiitis in Sweden, 2006–2019, a register-based study. Seminars in Arthritis and Rheumatism. 73. 152745–152745.
2.
Antovič, Aleksandra, et al.. (2022). Risks and treatment related aspects of COVID-19 infection in patients with ANCA-associated vasculitis. Scandinavian Journal of Rheumatology. 52(4). 418–423. 3 indexed citations
3.
Antovič, Aleksandra, et al.. (2021). POS1230 OUTCOME FOLLOWING COVID-19 INFECTION IN ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY (ANCA)-ASSOCIATED VASCULITIS. Annals of the Rheumatic Diseases. 80. 898–898. 1 indexed citations
4.
Antovič, Aleksandra, Annica Nordin, Ola Börjesson, et al.. (2020). Venous thromboembolism in anti-neutrophil cytoplasmic antibody-associated vasculitis: an underlying prothrombotic condition?. Rheumatology Advances in Practice. 4(2). rkaa056–rkaa056. 11 indexed citations
5.
Turesson, Carl, et al.. (2019). Swedish Society of Rheumatology 2018 guidelines for investigation, treatment, and follow-up of giant cell arteritis. Scandinavian Journal of Rheumatology. 48(4). 259–265. 32 indexed citations
6.
Antovič, Aleksandra, Elin Svensson, Ola Börjesson, Annette Bruchfeld, & Iva Gunnarsson. (2017). P-030: Venous thromboembolism (VTE) in patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) – underlying prothrombotic condition in active disease?. Thrombosis Research. 151. S119–S119. 1 indexed citations
7.
Knight, Ann, Yvonne Sundström, Ola Börjesson, et al.. (2016). Late-onset neutropenia after rituximab in ANCA-associated vasculitis. Scandinavian Journal of Rheumatology. 45(5). 404–407. 25 indexed citations
8.
Börjesson, Ola, Johan Bratt, Björn Anderstam, et al.. (2013). Macrophage Migration Inhibitory Factor (MIF) and Thyroid Hormone Alterations in Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis (AAV). Molecular Medicine. 19(1). 109–114. 9 indexed citations
9.
Gustafsson, Johanna, Iva Gunnarsson, Ola Börjesson, et al.. (2009). Predictors of the first cardiovascular event in patients with systemic lupus erythematosus - a prospective cohort study. Arthritis Research & Therapy. 11(6). R186–R186. 119 indexed citations
10.
Cao, Duojia, Ola Börjesson, P. Larsson, et al.. (2006). FOXP3 Identifies Regulatory CD25brightCD4+ T Cells in Rheumatic Joints. Scandinavian Journal of Immunology. 63(6). 444–452. 57 indexed citations
11.
Swanberg, Maria, Olle Lidman, Leonid Padyukov, et al.. (2005). MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction. Nature Genetics. 37(5). 486–494. 254 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zerai Manna Breakdown of academic impact, for papers by Haruka Tsuchiya Breakdown of academic impact, for papers by G Sturfelt Breakdown of academic impact, for papers by Mirko Scarsi Breakdown of academic impact, for papers by Y.W. Song Breakdown of academic impact, for papers by Tal Gazitt Breakdown of academic impact, for papers by Masahiro Ayano Breakdown of academic impact, for papers by Yoshie Sanayama Breakdown of academic impact, for papers by Hongyu Yang Breakdown of academic impact, for papers by Martin Judex
Rankless by CCL
2026